Sunshine Biopharma Inc
NASDAQ:SBFM

Watchlist Manager
Sunshine Biopharma Inc Logo
Sunshine Biopharma Inc
NASDAQ:SBFM
Watchlist
Price: 1.47 USD -1.34% Market Closed
Market Cap: 6.7m USD

Intrinsic Value

The intrinsic value of one SBFM stock under the Base Case scenario is 27.98 USD. Compared to the current market price of 1.47 USD, Sunshine Biopharma Inc is Undervalued by 95%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SBFM Intrinsic Value
27.98 USD
Undervaluation 95%
Intrinsic Value
Price
Worst Case
Base Case
Best Case
Compare SBFM to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SBFM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Sunshine Biopharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sunshine Biopharma Inc

Current Assets 27.9m
Cash & Short-Term Investments 10.3m
Receivables 3.6m
Other Current Assets 14m
Non-Current Assets 4.1m
PP&E 1.5m
Intangibles 2.5m
Other Non-Current Assets 92.3k
Efficiency

Free Cash Flow Analysis
Sunshine Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Sunshine Biopharma Inc

Revenue
36.3m USD
Cost of Revenue
-24.2m USD
Gross Profit
12.1m USD
Operating Expenses
-17.5m USD
Operating Income
-5.4m USD
Other Expenses
-873.9k USD
Net Income
-6.3m USD
Fundamental Scores

SBFM Profitability Score
Profitability Due Diligence

Sunshine Biopharma Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
ROIC is Increasing
Operating Margin is Increasing
Healthy Gross Margin
40/100
Profitability
Score

Sunshine Biopharma Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

SBFM Solvency Score
Solvency Due Diligence

Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

Sunshine Biopharma Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SBFM Price Targets Summary
Sunshine Biopharma Inc

Wall Street analysts forecast SBFM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SBFM is 7.14 USD with a low forecast of 7.07 USD and a high forecast of 7.35 USD.

Lowest
Price Target
7.07 USD
381% Upside
Average
Price Target
7.14 USD
386% Upside
Highest
Price Target
7.35 USD
400% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Sunshine Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for SBFM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

SBFM Insider Trading
Buy and sell transactions by insiders